prof. dr. Manon Spaander

Medicine and Dentistry

1. Abdominal Cancer 26%
2. Adenoma 25%
3. Barrett Esophagus 45%
4. Biopsy Technique 25%
5. Bite 9%
6. Cancer 9%
7. Cancer Incidence 11%
8. Cancer Risk 16%
9. Capsule Endoscopy 15%
10. Chemoradiotherapy 51%
11. Cohort Analysis 16%
12. Colon 22%
13. Colonoscopy 58%
14. Colorectal Cancer Screening 79%
15. Colorectal Carcinoma 100%
16. Colorectal Tumor 9%
17. Cost-Effectiveness Analysis 8%
18. COVID-19 8%
19. Diagnosis 15%
20. Diseases 17%
21. Dysplasia 36%
22. Endoscopic Surgery 10%
23. Endoscopy 29%
24. Esophageal Adenocarcinoma 21%
25. Esophageal Atresia 20%
26. Esophageal Cancer 43%
27. Esophageal Cancer 17%
28. Esophageal Squamous Cell Carcinoma 16%
29. Esophagectomy 18%
30. Gastrointestinal Endoscopy 14%
31. Hereditary Nonpolyposis Colorectal Cancer 17%
32. Malignant Neoplasm 22%
33. Meta-Analysis 10%
34. Minimal Residual Disease 9%
35. Neoadjuvant Therapy 9%
36. Neoplasm 55%
37. Occult Blood Test 70%
38. Overall Survival 20%
39. Plummer-Vinson Syndrome 13%
40. Polyp 26%
41. Prevalence 15%
42. Prospective Cohort Study 10%
43. Recurrent Disease 9%
44. Retrospective Cohort Study 9%
45. Screening 73%
46. Second Cancer 11%
47. Stent Placement 13%
48. Surgery 9%
49. Symptomatic Treatment 11%
50. Systematic Review 14%